Case Study: a Top 10 global pharmaceutical company achieves faster, lower-cost C&Q with Kneat Solutions

Standardizing C&Q For a Top 10 Global Pharma Company

A top 10 global pharmaceutical company sought to enhance its hybrid validation approach and eliminate inefficient, paper-based processes that hampered collaboration, compliance, and visibility across its global sites. To achieve standardization, efficiency, and cost savings, the company selected and implemented Kneat's digital validation platform, Kneat Gx.

By deploying Kneat's document-centric solution, the company standardized C&Q and validation processes across 15 sites. This implementation led to measurable results, including a 20-25% reduction in C&Q execution time, 20-25% cost savings on CAPEX projects, a 30-40% reduction in validation cycle time, and $900,000 in savings on a single project. Kneat also improved compliance, data integrity, and global collaboration for the organization.